IRB, Office of Research Development COOK COUNTY BUREAU OF HEALTH SERVICES
Office of Research Development

      
Friday, Nov 20, 2009
Home | Print this page | Email this page to a friend |
Developing Your Research
Rules & Regulations
Money
Taking Care?
 
  Institutional Links:
  CCH Intranet Links
  Cook County Bureau of   Health Services
  John Stroger Hospital
  Department of Medicine
  Educational Programs
  Email Access:
  CCHIL, RUSH & CCBHS
 

  IRB
  CCBHS
  627 S. Wood Street
  Chicago, IL 60612
  Phone: 312-864-0716
  Fax: 312-864-9210
 

SAFETY IN RESEARCH
 
Investigators who wish to use potentially hazardous agents in their research have an obligation to educate themselves and all others working with those agents about the proper ways to handle, store and dispose of them. The Centers for Disease Control publishes Biosafety in Microbiological and Biomedical Laboratories with which the investigator should be familiar. A copy can be found in the Research Resource Room, 603 Durand. A manual written for CDC's labs, General Laboratory Health and Safety may also be useful.

All research laboratories must comply with Hospital safety policies for handling, storing and disposing of potentially hazardous agents used in research. This policy applies to chemicals, biologic agents, radioisotopes, and agents used for recombinant DNA research.

Investigators responsible for overseeing research laboratory operations must maintain an up-to-date inventory of materials used in the area. Such inventories should include for every agent used research:

  1. Name of the agent
  2. Manufacturer
  3. Quantity currently stored
  4. Place of storage (Building and Room #)
  5. Copy of the MSDS Sheet

Copies of these inventories should be forwarded to the Hospital Safety Office at least annually or as requested by that office.

In addition to keeping up-to-date inventories, researchers who wish to bring hazardous materials to a Bureau site for the purpose of doing research must complete the Research Biosafety Form and obtain approval from the Safety Office, or in the case of radioisotopes, the Radiation Safety Officer. Protocols which involve the use of recombinant DNA techniques must be approved by the Recombinant DNA subcommittee of the Safety Committee.

This approval process applies only to hazardous agents acquired solely for research. Hazardous agents used in the course of clinical activities are governed by the Hospital's Safety Policy.

For more information, go to CDC's reference page on medical surveillance and safety.

Read the latest CCBHS Grants Newsletter
Send comments to ord@cchil.org

LOST A LINK? Look in the alphabetical index to links on this site

 
 
Home | Contact us | Privacy policy | Terms of use | Site Map

Copyright ©1998-2009 John Stroger Hospital. All rights reserved.
All information is not a substitute for medical advice or treatment for specific medical conditions.
If you have any health-care related questions or suspect you have a health problem, you should consult your health-care provider.